Amphastar Operating Margin from 2010 to 2024
| AMPH Stock | USD 39.62 0.00 0.00% |
Check Amphastar financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amphastar's main balance sheet or income statement drivers, such as Depreciation And Amortization of 43.9 M, Interest Expense of 28.5 M or Selling General Administrative of 46.2 M, as well as many indicators such as Price To Sales Ratio of 4.86, Dividend Yield of 0.0 or PTB Ratio of 4.9. Amphastar financial statements analysis is a perfect complement when working with Amphastar Valuation or Volatility modules.
Amphastar | Operating Margin |
Latest Amphastar's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Amphastar P over the last few years. It is Amphastar's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amphastar's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 0.30 % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Amphastar Operating Margin Regression Statistics
| Arithmetic Mean | 0.03 | |
| Geometric Mean | 0.05 | |
| Coefficient Of Variation | 662.58 | |
| Mean Deviation | 0.13 | |
| Median | (0.0001) | |
| Standard Deviation | 0.17 | |
| Sample Variance | 0.03 | |
| Range | 0.6034 | |
| R-Value | 0.75 | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.56 | |
| Significance | 0 | |
| Slope | 0.03 | |
| Total Sum of Squares | 0.42 |
Amphastar Operating Margin History
About Amphastar Financial Statements
Investors use fundamental indicators, such as Amphastar's Operating Margin, to determine how well the company is positioned to perform in the future. Although Amphastar's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California. Amphastar Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1761 people.
Currently Active Assets on Macroaxis
When determining whether Amphastar P offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Amphastar's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Amphastar P Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Amphastar P Stock:Check out the analysis of Amphastar Correlation against competitors. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amphastar. If investors know Amphastar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amphastar listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Earnings Share 3.01 | Revenue Per Share 14.942 | Quarterly Revenue Growth 0.059 | Return On Assets 0.0867 |
The market value of Amphastar P is measured differently than its book value, which is the value of Amphastar that is recorded on the company's balance sheet. Investors also form their own opinion of Amphastar's value that differs from its market value or its book value, called intrinsic value, which is Amphastar's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amphastar's market value can be influenced by many factors that don't directly affect Amphastar's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amphastar's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amphastar is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amphastar's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.